<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://mindmedicinelaw.com/briefing/mdma-assisted-therapy-for-social-anxiety-first-patient-insights-20261115-59151</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T22:04:28.078129+00:00</news:publication_date><news:title>MDMA-Assisted Therapy for Social Anxiety: First Patient Insights</news:title><news:keywords>mdma-assisted therapy, social anxiety disorder, qualitative research, patient experience, mental health policy, clinical trial design, psychedelic research, regulatory implications, therapeutic mechanisms</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/mdma-assisted-therapy-for-social-anxiety-first-qualitative-insights-20261115-58980</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T15:05:37.996409+00:00</news:publication_date><news:title>MDMA-Assisted Therapy for Social Anxiety: First Qualitative Insights</news:title><news:keywords>mdma-assisted therapy, social anxiety disorder, qualitative research, patient experience, psychedelic clinical trials, therapeutic mechanisms, emotional processing, self-compassion, regulatory implications, psychiatric innovation</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/iv-ketamine-in-treatment-resistant-bipolar-depression-early-clinical-trial-resul-20261114-59179</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T22:04:41.151831+00:00</news:publication_date><news:title>IV Ketamine in Treatment-Resistant Bipolar Depression: Early Clinical Trial Results</news:title><news:keywords>ketamine, bipolar depression, treatment-resistant depression, clinical trial, iv ketamine, psychiatric safety, regulatory policy, mood disorders, antidepressant mechanism</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/trait-absorption-predicts-ketamine-response-in-trd-musik-trial-insights-20261114-58995</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T15:05:24.949522+00:00</news:publication_date><news:title>Trait Absorption Predicts Ketamine Response in TRD: MUSIK Trial Insights</news:title><news:keywords>ketamine therapy, trait absorption, treatment-resistant depression, music-based support, psychedelic-assisted therapy, clinical trial, personalized medicine, drug-context interaction, mystical experience, mental health policy</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/blood-plasma-biomarkers-guide-psilocybin-ketamine-use-in-depression-20261114-59081</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T15:05:04.595257+00:00</news:publication_date><news:title>Blood Plasma Biomarkers Guide Psilocybin, Ketamine Use in Depression</news:title><news:keywords>psilocybin, ketamine, depression, biomarkers, personalized medicine, companion diagnostics, psychedelic clinical trials, regulatory policy, precision psychiatry</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/breathwork-mimics-psychedelic-neural-states-eeg-study-insights-20261113-59131</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T22:04:53.415243+00:00</news:publication_date><news:title>Breathwork Mimics Psychedelic Neural States: EEG Study Insights</news:title><news:keywords>breathwork, psychedelic states, eeg, altered states of consciousness, non-pharmacological interventions, mental health research, neural dynamics, clinical implications, regulatory policy</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/ayahuasca-and-mental-health-2022-2026-clinical-evidence-review-20261113-58996</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T15:05:54.739267+00:00</news:publication_date><news:title>Ayahuasca and Mental Health: 2022–2026 Clinical Evidence Review</news:title><news:keywords>ayahuasca, mental health, clinical trials, psychedelic research, safety risks, observational studies, policy implications, depression, anxiety, efficacy evidence</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/spacoda-advances-spatial-transcriptomics-for-brain-research-20261113-58811</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-14T22:05:17.515234+00:00</news:publication_date><news:title>SpaCoDA Advances Spatial Transcriptomics for Brain Research</news:title><news:keywords>spatial transcriptomics, spacoda, cellular niches, neuropsychiatric research, psychedelic science, computational biology, glioblastoma, breast cancer, clinical trials, brain tissue analysis</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/safety-and-implementation-of-ketamine-psilocybin-and-rtms-for-trd-2026-review-20261113-58838</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-14T22:05:04.853693+00:00</news:publication_date><news:title>Safety and Implementation of Ketamine, Psilocybin, and rTMS for TRD: 2026 Review</news:title><news:keywords>treatment-resistant depression, ketamine, psilocybin, esketamine, rTMS, safety monitoring, maintenance strategies, implementation research, psychedelic-assisted therapy, real-world outcomes</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/validated-uplc-ms-ms-assay-for-esketamine-metabolites-in-beagle-dogs-20261112-58840</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-14T22:05:47.288533+00:00</news:publication_date><news:title>Validated UPLC-MS/MS Assay for Esketamine Metabolites in Beagle Dogs</news:title><news:keywords>esketamine, pharmacokinetics, beagle dog model, UPLC-MS/MS, bioanalytical validation, noresketamine, hydroxynoresketamine, antidepressant research, psychedelic drug development</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/critique-of-entropic-brain-and-irruption-theories-in-psychedelic-neuroscience-20261112-58792</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-14T22:05:31.057930+00:00</news:publication_date><news:title>Critique of Entropic Brain and Irruption Theories in Psychedelic Neuroscience</news:title><news:keywords>entropic brain hypothesis, irruption theory, neural entropy, psychedelic neuroscience, consciousness research, subjective experience, neuroimaging, clinical trial endpoints, philosophy of mind</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/intranasal-nanocarrier-cns-delivery-lessons-for-psychedelic-trials-20261110-58584</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-14T15:04:17.984929+00:00</news:publication_date><news:title>Intranasal Nanocarrier CNS Delivery: Lessons for Psychedelic Trials</news:title><news:keywords>intranasal delivery, nanocarriers, central nervous system, multiple sclerosis, psychedelic research, drug delivery, clinical translation, pharmacokinetics, regulatory science</news:keywords></news:news></url><url><loc>https://mindmedicinelaw.com/briefing/audit-of-llm-mental-health-recommendations-psychedelic-guidance-and-regulatory-g-20261109-58534</loc><news:news><news:publication><news:name>The Psychedelic Journal</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-14T15:04:31.477052+00:00</news:publication_date><news:title>Audit of LLM Mental Health Recommendations: Psychedelic Guidance and Regulatory Gaps</news:title><news:keywords>large language models, mental health interventions, psychedelic therapies, clinical recommendations, ai regulation, audit, digital health, risk assessment, ethics, patient safety</news:keywords></news:news></url></urlset>